Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NGM Bio Announces Positive Preliminary Topline Liver Histology of Aldafermin in NASH Patients

americanpharmaceuticalreviewMarch 10, 2020

Tag: NGM Biopharmaceuticals , Aldafermin , NASH , liver

PharmaSources Customer Service